GENEVA, July 2 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/062867) for "NITROGEN-CONTAINING HETEROARYL COMPOUNDS FOR THE TREATMENT OF CHRONIC DISEASES" on Dec 19, 2024. With publication no. WO/2025/133961, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHOI, Chulho (c/o Pfizer Inc.445 Eastern Point RoadBuilding 98Groton, Connecticut 06340), CHUBA, Matthew David (c/o Pfizer Inc.445 Eastern Point RoadBuilding 98Groton, Connecticut 06340), FOLEY, Timothy Leyd...